April 28, 2026

Proton Therapy in Early-Onset Locally Advanced Rectal Cancer: The Importance of Fertility-Preserving Multimodality Care

The rising incidence and mortality of early-onset colorectal cancer (EOCRC), defined as disease occurring in patients younger than 50, has emerged as a clinically significant trend with implications for screening, diagnosis, and survivorship.

Baptist Health South Florida

April 23, 2026

Adaptive Radiation Therapy for Men with Intermediate- or High-Risk Prostate Cancer (DE-CART)

The goal of this clinical trial is to evaluate if adaptive stereotactic body radiation therapy (SBRT) is a safe and effective way to treat prostate cancer in adults. It will assess the safety profile of adaptive SBRT over time.

Fox Chase Cancer Center

April 20, 2026

For Most Men With Prostate Cancer, Hormone Therapy With Postprostatectomy Radiotherapy Confers No Survival Benefit

Adding hormone therapy to postprostatectomy radiotherapy may provide little survival benefit for most men with prostate cancer, especially those with very low prostate-specific antigen (PSA) levels be...

The ASCO Post

April 17, 2026

Radiology Groups Push Back on New Cancer Screening Guidelines

Radiology groups say the ACP's new screening recommendations conflict with nearly every major cancer organization and could cost thousands of lives annually.

Conexiant

April 06, 2026

Fullerene Cream vs Trolamine Cream in Reducing Acute Radiation Dermatitis From Radiation Therapy for Head and Neck Cancer

In a single-center Chinese phase II trial reported in the Journal of Clinical Oncology, Liu et al found that fullerene cream was better than trolamine cream in reducing risk for acute radiation dermat...

The ASCO Post

April 02, 2026

ACC/AHA Consensus Sets Tricuspid Program Standards

Multisociety document outlines operator, institutional, and registry requirements as transcatheter tricuspid therapies expand

Conexiant

March 30, 2026

Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery

These results come from the pilot phase of the phase III ADARNAT randomized international clinical trial, which is investigating whether axillary radiotherapy has a lower risk of lymphedema than axill...

The ASCO Post

March 20, 2026

Hypofractionated Locoregional RT in Early Breast Cancer

As reported in The Lancet by Rivera et al, 5-year results of a French phase III trial (UNICANCER HypoG-01) showed noninferiority of hypofractionated locoregional radiotherapy (RT) vs standard 5-week R...

The ASCO Post

March 04, 2026

Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Entrustable Professional Activities

A study highlights the evolving role of advanced practice providers in radiation oncology, revealing gaps in training and the potential for improved patient care.

JADPRO

March 02, 2026

Stereotactic vs Whole-Brain Radiation for Patients With Brain Metastases

Among patients with 5 to 20 brain metastases, does stereotactic radiation targeting individual tumors reduce symptom burden and improve daily function over hippocampal-avoidance whole-brain radiation?...

The ASCO Post